-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.O3.6 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Immunologic and Metabolic Biomarkers of Disease Control

Symposia: Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
immune mechanism, Diseases, immunology, Myeloid Malignancies, Biological Processes, molecular biology, Minimal Residual Disease
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Room 6CF (San Diego Convention Center)
Moderators:
Lina Benajiba, MD, PhD, Université Paris Cité, APHP, Hôpital Saint-Louis and Sergio Rutella, MD, PhD, FRCPath, Nottingham Trent University
Disclosures:
Benajiba: Gilead: Research Funding; Pfizer: Research Funding; GSK: Honoraria; BMS: Honoraria. Rutella: Wugen: Research Funding.
4:00 PM

Danielle C Kirkey, MD1,2, Leila Robinson1*, Derek Janssens, PhD3*, Margaret G Hines4*, Tiffany Hylkema, BS5*, Makia K Manselle1*, Rhonda E Ries, MA5*, Jack H Peplinski, BS5*, Logan K Wallace1*, Dominik Otto, PhD3*, Katherine Tarlock, MD1,6, Steven Henikoff, PhD3*, Wei Li, PhD4* and Soheil Meshinchi, MD, PhD7

1Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
2Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA
3Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
4Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA
5Translational Sciences and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
6Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
7Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA

4:15 PM

Jayakumar Vadakekolathu, PhD1*, Heidi Altmann, PhD2*, Manja Wobus2*, Malte von Bonin, MD2*, Marc Schmitz, MD3,4*, Gustavo B. Baretton, MD5*, Robert Zeiser, MD6, Martin Bornhäuser, MD7,8* and Sergio Rutella, MD, PhD, FRCPath1

1John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom
2Department of Internal Medicine I, University Hospital, TU Dresden, Dresden, Germany
3Institute for Immunology, University Hospital, TU Dresden, Dresden, Germany
4National Center for Tumor Diseases (NCT/UCC) Dresden, TU Dresden, Dresden, Germany
5Institute for Pathology, University Hospital, TU Dresden, Dresden, Germany
6Department of Medicine I, Medical Center University of Freiburg, Freiburg, Germany
7Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
8National Center for Tumor Diseases (NCT/UCC) Dresden, Technical University Dresden, Dresden, Germany

4:30 PM

Bettina Nadorp, PhD1,2,3*, Audrey Lasry, PhD2,3*, Sanam Loghavi, MD4, Ravi Patel5*, Ben Kelly6*, Christopher J. Walker, PhD7,8*, Stephanie LaHaye9*, Jill Buss, BS8,10, Isaiah Boateng8*, Karen Nahmod, MD, PhD11*, Adrienne Heyrosa8*, Helee Desai8*, Andrea Langanson8*, Hasan Abaza8*, Linda Procell2*, Tejas Patel2*, Benjamin Kaffenberger8*, Saranga Wijeratne12*, Maria Guillamot Ruano, PhD, PharmD2*, Anna Yeaton, PhD2*, Geraldine Cayanan, PhD2*, Maria Velegraki13*, Zihai Li, MD, PhD13, Kieran D Sahasrabudhe, MD14, Lynne V. Abruzzo, MD, PhD8, Daniel Pollyea15, Christine M. McMahon16, Arwa Shana'Ah8*, John C. Byrd, MD8, Aristotelis Tsirigos, PhD1,2, Elaine R Mardis, PhD8*, Alice Mims, MD17,18, Iannis Aifantis, PhD2,18 and Ann-Kathrin Eisfeld, MD*7,14,18

1Division of Precision Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, NY
2Department of Pathology, NYU Grossman School of Medicine, New York, NY
3equal contribution, *
4Hematopathology, MD Anderson Cancer Center, Houston, TX
5The Ohio State Comprehensive Cancer Center, Columbus, OH
6Nationwide Children's Hospital and Ohio State University College of Medine, Columbus, OH
7Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH
8The Ohio State University Comprehensive Cancer Center, Columbus, OH
9The Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH
10Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
11Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX
12The Steve and Cindy Rasmussen Institute For Genomic Medicine, Abigail Wexner Res, Columbus, OH
13Pelotonia Institute for Immunology-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
14Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
15University of Colorado, Aurora, CO
16University of Colorado School of Medicine, Aurora, CO
17Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
18equal contribution, #

4:45 PM

Dominic Fowler-Shorten, BSc1*, Rebecca S Maynard, MSc1*, Katherine Hampton, MSc, BSc1*, Martha Ehikioya1*, Edyta E Wojtowicz, PhD2*, Kristian Bowles, MBBS, PhD1,3, Stuart Rushworth, PhD1 and Charlotte Hellmich, PhD, BSc, MBBChir1,3

1Norwich Medical School, University of East Anglia, Norwich, United Kingdom
2Earlham Institute, Norwich, United Kingdom
3Norfolk and Norwich University Hospital, Norwich, United Kingdom

5:00 PM

Isabel Weinhaeuser, PhD1*, Diego Pereira-Martins, PhD1*, Dominique Sternadt, MSc1*, Emmanuel F Griessinger, Ph.D.1*, Douglas RA Silveira, MD, PhD2*, Juan L Coelho-Silva, Ph.D.3*, Antonio Bruno Alves-Silva, MSc4*, Ayşegül Erdem, Ph.D.5*, Bruno Koza Lino Duarte, MD6*, Lynn Quek, MD, PhD7*, Fabiola Traina, MD, PhD8, Sara Teresinha Olalla Saad, MD9, Jacobien R Hilberink, MD, BSc1*, Emanuele Ammatuna, MD, PhD1*, Eduardo Magalhães Rego, MD, PhD10,11, Gerwin A. Huls, Prof.12, Antonio R Lucena-Araujo, Prof.3* and Jan Jacob Schuringa, PhD13

1Department of Experimental Hematology, University Medical Centre Groningen, Groningen, Netherlands
2School of Cancer and Pharmaceutical Sciences, King's College London, London, ENG, United Kingdom
3Department of Genetics, Federal University of Pernambuco, Recife, Brazil
4Department of Medical Images, Haematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil
5Cellular Metabolism and Microenvironment Laboratory, de Duve Institute, UCLouvain, Brussels, Belgium
6Centro de Hematologia e Hemoterapia, Universidade Estadual de Campinas, Caminas, Brazil
7Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom
8Department of Medical Images, Hematology, and Oncology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil
9Hematology and Transfusion Medicine Center - University of Campinas/Hemocentro-UNICAMP, Campinas, São Paulo, Brazil
10Hematology Service, LIM-31 and State of Sao Paulo Cancer Institute, University of São Paulo, Faculdade de Medicina, São Paulo, São Paulo, Brazil
11Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, BRA
12Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
13Department of Experimental Hematology, University Medical Center - Groningen, Groningen, Netherlands

5:15 PM

Guo Qiu1*, Xi Xu2*, Huiwen Xue2*, Tian Zhang3*, Li Xuan4* and Qifa Liu, MD1

1Nanfang Hospital, Southern Medical University, Guangzhou, China
2Nanfang Hospital, Southern Medical University, Guangzhou, CHN
3Nanfang Hospital, Southern Medical University, Guang Zhou, China
4Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

*signifies non-member of ASH